Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (53 quarters reported)
$9B in Q2 2013 → $4.82B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| BD Bobs Disc Furniture Inc | 31.3% | Unchanged | 95,370,751 | $1.51B |
| Surgery Partners Inc | 17.4% | Unchanged | 49,946,972 | $839M |
| AH Aveanna Healthcare Hldgs Inc | 14.5% | Unchanged | 81,600,880 | $699M |
| KM Kestra Med Technologies Ltd | 13.3% | Unchanged | 25,172,338 | $640M |
| Kailera Therapeutics Inc | 12.0% | New | 26,255,581 | $578M |
| Nutanix Inc | 5.7% | Unchanged | 5,355,285 | $273M |
| WH Waystar Hldg Corp | 5.6% | Unchanged | 13,243,539 | $272M |
| Advantage Solutions Inc | 0.1% | Unchanged | 115,600 | $5M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Kailera Therapeutics Inc | New | +26,255,581 | +$578M | 12.0% |
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Coherent Corp | Exited | −9,775,846 | −$1.8B | — |
| BD Bobs Disc Furniture Inc | New | +95,370,751 | +$1.12B | 34.3% |
| Advantage Solutions Inc | Exited | −2,890,000 | −$2.54M | — |
| Advantage Solutions Inc | New | +115,600 | +$2.44M | 0.1% |
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Coherent Corp | New | +9,775,846 | +$1.8B | 39.0% |
| KM Kestra Med Technologies Ltd | Trimmed | −1,846,887 | −$49M | 14.4% |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| WH Waystar Hldg Corp | Trimmed | −4,811,510 | −$182M | 15.0% |
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Nutanix Inc | Trimmed | −5,605,650 | −$428M | 13.1% |
| WH Waystar Hldg Corp | Trimmed | −3,699,487 | −$151M | 23.5% |
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KM Kestra Med Technologies Ltd | New | +27,019,225 | +$673M | 17.3% |
| Nutanix Inc | Trimmed | −5,893,097 | −$411M | 19.7% |
| WH Waystar Hldg Corp | Trimmed | −6,225,881 | −$233M | 20.9% |
quarter ended December 31, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Cerevel Therapeutics Hldng I | Exited | −65,679,781 | −$2.69B | — |
| Nutanix Inc | New | +16,854,032 | +$999M | 26.1% |
Loading...
